Published in Cancer Weekly, July 31st, 2001
D. Jones and colleagues at the University of Texas M.D. Anderson Cancer Center, Houston, Texas, conducted a study to evaluate "surface CD26 expression in 271 peripheral blood samples from 154 patients evaluated for the presence of a T-cell lymphoproliferative disorder, primarily mycosis fungoides/Sezary syndrome (MF/SS)." The results of their study were published in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.